Andreas Grauer
CIK: 0001770511
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SGMT
Sagimet Biosciences Inc.
Officer
Discretionary Trading P&L
Holdings
About Grauer Andreas
Grauer Andreas (SEC CIK 0001770511) files insider reports with the SEC as Chief Medical Officer of Sagimet Biosciences Inc. (SGMT).
Signal8 holds 3 ownership filings by Grauer Andreas (1 Form 3, 2 Form 4), filed between May 14, 2026 and Jun 1, 2026. Those filings report 2 transactions, from Apr 20, 2026 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Grauer Andreas's filings is in SAN MATEO, CA.
Recent filings by Grauer Andreas
Other insiders filing for Sagimet Biosciences Inc. (SGMT)
- Kemble George, Director
- Happel David, President & CEO
- Rozek Elizabeth, Chief Legal & Admin. Officer
- SEIDENBERG BETH C, Director
- Hoelscher Paul W., Director
- Jarrett Jennifer, Director